Posts

Posted on

HG Re Ltd. Selects Clearwater Analytics for Performance Attribution and Risk Management

HG Re Ltd. Selects Clearwater Analytics for Performance Attribution and Risk Management

BOISE, Idaho & CHICAGO & NEW YORK & LONDON–(BUSINESS WIRE)–Clearwater Analytics (NYSE: CWAN), the most comprehensive technology platform for investment management, today announced that HG Re Ltd. has selected Clearwater to enhance its investment performance measurement and risk analytics capabilities. This implementation will provide HG Re with advanced tools to support data-driven investment decisions and improve portfolio oversight.

By adopting Clearwater, HG Re is streamlining its operations and gaining more direct control over investment performance and risk management—reducing its reliance on custodial and external service providers. The solution offers real-time access to portfolio insights, such as risk assessment, performance attribution, shock analysis, and scenario modeling.

“In today’s dynamic market environment, we needed sophisticated capabilities to navigate uncertainty and manage risk effectively,” said Gerhard Lubbe, CFO of HG Re Ltd. “Clearwater’s comprehensive platform delivers real-time insights and advanced analytics, enabling us to respond quickly to market shifts while maintaining precise control over our portfolio’s risk exposure. This technology empowers us to shift from reactive to proactive risk management while ensuring our investment strategies align with our risk parameters.”

“We’re seeing a clear trend across our global clients seeking technology solutions that provide deeper insights into risk and performance,” said Kirat Singh, President, Risk and Alternative Assets, Clearwater Analytics. “As market conditions become increasingly complex, our advanced risk and performance attribution capabilities help leading organizations like HG Re assess market impacts, conduct scenario analysis, and make data-driven decisions that optimize their portfolio performance while maintaining strong risk management practices.”

Discover how Clearwater Analytics can transform your investment management strategy and drive operational excellence by speaking to an expert today.

About Clearwater Analytics

Clearwater Analytics (NYSE: CWAN) is transforming investment management with the industry’s most comprehensive cloud-native platform for institutional investors across global public and private markets. While legacy systems create risk, inefficiency, and data fragmentation, Clearwater’s single-instance, multi-tenant architecture delivers real-time data and AI-driven insights throughout the investment lifecycle. The platform eliminates information silos by integrating portfolio management, trading, investment accounting, reconciliation, regulatory reporting, performance, compliance, and risk analytics in one unified system. Serving leading insurers, asset managers, hedge funds, banks, corporations, and governments, Clearwater supports over $8.8 trillion in assets globally. Learn more at www.clearwateranalytics.com.

Media Contact:

Claudia Cahill, Head of Communications and PR | +1 208-433-1200 | [email protected]

KEYWORDS: Europe United States United Kingdom North America Illinois Idaho New York

INDUSTRY KEYWORDS: Software Finance Asset Management Artificial Intelligence Data Management Professional Services Technology Fintech

MEDIA:

Logo
Logo
Posted on

Affirm and PGIM expand long-term capital partnership to invest up to $3 billion via revolving pass-through loan sale facility

Affirm and PGIM expand long-term capital partnership to invest up to $3 billion via revolving pass-through loan sale facility

SAN FRANCISCO–(BUSINESS WIRE)–
Affirm (NASDAQ: AFRM), the payment network that empowers consumers and helps merchants drive growth, and PGIM Fixed Income, a Prudential Financial (NYSE: PRU) company and one of the largest global fixed income managers with $862 billion in assets under management1, today announced the expansion of their capital partnership with a new revolving pass-through loan sale facility that will invest up to $3 billion over 36 months by purchasing up to $500 million of Affirm loans at any one time.

This unique revolving pass-through facility follows PGIM’s earlier private purchase of $500 million in Affirm loans in December 2024 as well as previous investments in Affirm’s assets via the company’s asset-backed securitizations. PGIM manages a leading asset-based finance platform with more than $145 billion in assets under management across public and private securitized credit1.

“PGIM is proud to expand our longstanding collaboration with Affirm. This agreement is a further testament to our commitment to finding durable sources of risk-adjusted returns for our clients through our selective origination process,” said Edwin Wilches, co-head of Securitized Products at PGIM Fixed Income. “This innovative pass-through facility showcases our ability to find attractive opportunities across public and private markets and how our access to diverse pools of capital can deliver value to our partners.”

“We are always in constant dialogue with our capital partners to better understand their needs and how we can deliver even more value to them,” said Brooke Major-Reid, Chief Capital Officer of Affirm. “This first-of-its-kind facility for Affirm and PGIM does exactly that and demonstrates how we can utilize innovative structures to create winning partnerships. We greatly appreciate the PGIM team’s support for our mission to deliver honest financial products that improve lives.”

Affirm empowers consumers with a transparent and flexible way to pay over time without any late or hidden fees. The company generated over $33 billion in gross merchandise volume (GMV) for the last twelve months ending March 31, 2025. With a diverse and durable funding model across multiple channels, Affirm’s total funding capacity grew to $23.3 billion as of March 31, 2025, marking the ninth consecutive quarter that funding capacity increased. As a scaled and programmatic issuer, Affirm has issued 23 asset-backed securitizations totaling $11.5 billion with participation from over 150 unique capital partners across institution types, including: alternative asset managers, insurance companies, pension funds, sovereign wealth funds, hedge funds, and banks.

1 As of March 31, 2025

About Affirm

Affirm’s mission is to deliver honest financial products that improve lives. By building a new kind of payment network—one based on trust, transparency, and putting people first—we empower millions of consumers to spend and save responsibly, and give thousands of businesses the tools to fuel growth. Unlike most credit cards and other pay-over-time options, we never charge any late or hidden fees. Follow Affirm on social media: LinkedIn | Instagram | Facebook | X.

About PGIM FIXED INCOME

PGIM Fixed Income, with $862 billion in assets under management as of March 31, 2025, is a global asset manager offering active solutions across all fixed income markets. The company has offices in Newark, N.J., London, Amsterdam, Zurich, Munich, Paris, Singapore, Sydney, Hong Kong, and Tokyo. For more information, visit https://www.pgim.com/us/en/institutional/businesses/fixed-income.

AFRM-PA

Media

Affirm: [email protected]

PGIM: [email protected]

Investors

Affirm: [email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Banking Asset Management Professional Services Finance

MEDIA:

Posted on

Robin Energy Ltd. Announces Pricing of $4.5 Million Registered Direct Offering

LIMASSOL, Cyprus, June 18, 2025 (GLOBE NEWSWIRE) — Robin Energy Ltd. (NASDAQ:RBNE) (“Robin Energy” or the “Company”), an international ship-owning company providing energy transportation services globally, today announced that it has entered into a securities purchase agreement with several institutional investors to purchase 860,000 common shares at an offering price of $5.25, for gross proceeds of approximately $4.5 million (the “Offering”), before deducting commissions and offering expenses, in a registered direct offering.

Maxim Group LLC is acting as the sole placement agent for the Offering.

Robin Energy currently intends to use the net proceeds from the Offering for working capital and general corporate purposes. The Offering is expected to close on or about June 20, 2025 (the “Closing Date”), subject to the satisfaction of customary closing conditions.

The Offering is being made pursuant to an effective shelf registration statement on Form F-3, (File No. 333-286726) previously filed with and subsequently declared effective by the U.S. Securities and Exchange Commission (“SEC”) on April 28, 2025. A prospectus supplement relating to the securities to be issued in the Offering will be filed by the Company with the SEC. When available, copies of the prospectus supplement relating to the Offering, together with the accompanying prospectus, can be obtained at the SEC’s website at www.sec.gov or by contacting Maxim Group LLC, at 300 Park Avenue, 16th Floor, New York, NY 10022, Attention: Syndicate Department, or via email at [email protected] or by telephone at (212) 895-3745.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.


About Robin Energy Ltd.

Robin Energy is an international ship-owning company providing energy transportation services globally. Robin currently owns one Handysize tanker vessel that carries petroleum products worldwide.

For more information, please visit the Company’s website at www.robinenergy.com. Information on our website does not constitute a part of this press release.


Cautionary Statement Regarding Forward-Looking Statements

Matters discussed in this press release may constitute forward-looking statements. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements, which are other than statements of historical facts, including those related to the completion and timing of the offering and the intended use of the proceeds. We are including this cautionary statement in connection with this safe harbor legislation. The words “believe”, “anticipate”, “intend”, “estimate”, “forecast”, “project”, “plan”, “potential”, “will”, “may”, “should”, “expect”, “pending” and similar expressions identify forward-looking statements.

Forward-looking statements are subject to risks, uncertainties and other factors because they relate to events and depend on circumstances that may or may not occur in the future and/or are beyond our control or precise estimate. Such risks, uncertainties and other factors include, but are not limited to, uncertainties related to the Company’s and its counterparty’s ability to consummate the transactions discussed herein, as well as those factors discussed under “Risk Factors” in our Annual Report on Form 20-F for the year ended December 31, 2024 and our other filings with the SEC, which can be obtained free of charge on the SEC’s website at http://www.sec.gov. Except to the extent required by applicable law, we disclaim any intention or obligation to update publicly or revise any forward‐looking statements, whether as a result of new information, future events or otherwise.


CONTACT DETAILS

For further information please contact:

Petros Panagiotidis
Robin Energy Ltd.
Email: [email protected]



Posted on

ACNB Corporation Announces Common Stock Repurchase Program

GETTYSBURG, Pa., June 18, 2025 (GLOBE NEWSWIRE) — ACNB Corporation (“ACNB”) (NASDAQ: ACNB), financial holding company for ACNB Bank and ACNB Insurance Services, Inc., announced today that the Board of Directors approved a new plan to repurchase, in open market transactions at prevailing market prices, up to 314,000, or approximately 3.0%, of the outstanding shares of ACNB’s common stock. The amount and timing of any shares repurchased will be evaluated and determined by management in its discretion and will depend upon a number of factors, including ACNB’s capital position, liquidity, financial performance and alternate uses of capital, the market price of ACNB’s securities, general market and economic conditions, and applicable legal and regulatory requirements, with no guarantee as to the exact number of shares that will be repurchased. The common stock repurchases are expected to be funded by using available capital. Further, this new common stock repurchase program replaces and supersedes any and all earlier announced repurchase plans.

ACNB Corporation, headquartered in Gettysburg, PA, is the independent $3.27 billion financial holding company for the wholly-owned subsidiaries of ACNB Bank, Gettysburg, PA, including its operating divisions Traditions Bank and Traditions Mortgage, and ACNB Insurance Services, Inc., Westminster, MD. Originally founded in 1857, ACNB Bank serves its marketplace with banking and wealth management services, including trust and retail brokerage, via a network of 33 community banking offices and one loan offices located in the Pennsylvania counties of Adams, Cumberland, Franklin, Lancaster and York and the Maryland counties of Baltimore, Carroll and Frederick. ACNB Insurance Services, Inc. is a full-service insurance agency with licenses in 46 states. The agency offers a broad range of property, casualty, health, life and disability insurance serving personal and commercial clients through office locations in Westminster, MD, and Gettysburg, PA. For more information regarding ACNB Corporation and its subsidiaries, please visit investor.acnb.com.

FORWARD-LOOKING STATEMENTS – In addition to historical information, this press release may contain forward-looking statements. Examples of forward-looking statements include, but are not limited to, (a) projections or statements regarding future earnings, expenses, net interest income, other income, earnings or loss per share, asset mix and quality, growth prospects, capital structure, and other financial terms, (b) statements of plans and objectives of Management or the Board of Directors, and (c) statements of assumptions, such as economic conditions in the Corporation’s market areas. Such forward-looking statements can be identified by the use of forward-looking terminology such as “believes”, “expects”, “may”, “intends”, “will”, “should”, “anticipates”, or the negative of any of the foregoing or other variations thereon or comparable terminology, or by discussion of strategy. Forward-looking statements are subject to certain risks and uncertainties such as national, regional and local economic conditions, competitive factors, and regulatory limitations. Actual results may differ materially from those projected in the forward-looking statements. Such risks, uncertainties, and other factors that could cause actual results and experience to differ from those projected include, but are not limited to, the following: short-term and long-term effects of inflation and rising costs on the Corporation, customers and economy; effects of governmental and fiscal policies, as well as legislative and regulatory changes; effects of new laws and regulations (including laws and regulations concerning taxes, banking, securities and insurance) and their application with which the Corporation and its subsidiaries must comply; impacts of the capital and liquidity requirements of the Basel III standards; effects of changes in accounting policies and practices, as may be adopted by the regulatory agencies, as well as the Financial Accounting Standards Board and other accounting standard setters; ineffectiveness of the business strategy due to changes in current or future market conditions; future actions or inactions of the United States government, including the effects of short-term and long-term federal budget and tax negotiations and a failure to increase the government debt limit or a prolonged shutdown of the federal government; effects of economic conditions particularly with regard to the negative impact of any pandemic, epidemic or health-related crisis and the responses thereto on the operations of the Corporation and current customers, specifically the effect of the economy on loan customers’ ability to repay loans; effects of competition, and of changes in laws and regulations on competition, including industry consolidation and development of competing financial products and services; inflation, securities market and monetary fluctuations; risks of changes in interest rates on the level and composition of deposits, loan demand, and the values of loan collateral, securities, and interest rate protection agreements, as well as interest rate risks; difficulties in acquisitions and integrating and operating acquired business operations, including information technology difficulties; challenges in establishing and maintaining operations in new markets; effects of technology changes; effects of general economic conditions and more specifically in the Corporation’s market areas; failure of assumptions underlying the establishment of reserves for loan losses and estimations of values of collateral and various financial assets and liabilities; acts of war or terrorism or geopolitical instability; disruption of credit and equity markets; ability to manage current levels of impaired assets; loss of certain key officers; ability to maintain the value and image of the Corporation’s brand and protect the Corporation’s intellectual property rights; continued relationships with major customers; and, potential impacts to the Corporation from continually evolving cybersecurity and other technological risks and attacks, including additional costs, reputational damage, regulatory penalties, and financial losses. We caution readers not to place undue reliance on these forward-looking statements. They only reflect Management’s analysis as of this date. The Corporation does not revise or update these forward-looking statements to reflect events or changed circumstances. Please carefully review the risk factors described in other documents the Corporation files from time to time with the SEC, including the Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q. Please also carefully review any Current Reports on Form 8-K filed by the Corporation with the SEC.

ACNB #2025-11
June 18, 2025

Contact: Kevin J. Hayes
  SVP/General Counsel,
  Secretary & Chief
  Governance Officer
  717.339.5161
  [email protected]



Posted on

Progress Software CEO Yogesh Gupta Named an EY US Entrepreneur Of The Year® 2025 New England Award Winner

Visionary CEO recognized for bold leadership, strategic growth, accelerated AI innovation and long-term stakeholder value creation

BURLINGTON, Mass., June 18, 2025 (GLOBE NEWSWIRE) — Progress Software (Nasdaq: PRGS), the trusted provider of AI-powered digital experience and infrastructure software, today announced that CEO Yogesh Gupta has been named an Entrepreneur Of The Year® 2025 New England Award winner by Ernst & Young LLP (EY US). The prestigious program recognizes visionary leaders of companies who are driving innovation, accelerating growth and creating lasting impact for future generations.

Since joining Progress in 2016, Gupta has driven significant growth and transformation at the company. Under his leadership, Progress has more than doubled in size, completed five strategic acquisitions—including the landmark 2024 purchase of ShareFile, the company’s largest acquisition to date—and successfully executed its Total Growth Strategy, focusing on innovation, disciplined mergers and acquisitions, and customer retention. Gupta’s foresight in navigating market shifts, especially in AI, has positioned Progress ahead of the curve, consistently delivering value to a global client base that includes over 75% of the Fortune 500.

“I am deeply honored to receive this recognition from EY,” said Gupta. “Entrepreneurship is about more than building a business—it’s about building a future. I’m proud to lead a company that innovates not only in technology but also invests in people, communities and purpose.”

Gupta’s entrepreneurial approach is shaped by a personal journey defined by resilience, ambition and a deep belief in innovation’s power. Since becoming CEO, he has cultivated a culture of agility, strategic risk-taking and operational excellence across the organization. Progress has achieved record revenues and doubled its global workforce from 1,500 to 3,000 employees during his tenure. Renowned for his sharp business insight and people-centric leadership, Gupta actively mentors employees and engages with teams worldwide, fostering a culture grounded in excellence, teamwork, respect and sustainable value creation.

Gupta was chosen by an independent panel of past winners, top CEOs and business leaders. Judges assessed candidates on long-term value creation, entrepreneurial spirit, purpose-driven commitment and significant growth and impact.

As a New England award winner, he is now eligible for consideration for the Entrepreneur Of The Year 2025 National Awards. The National Award winners, including the Entrepreneur Of The Year National Overall Award winner, will be announced in November 2025.

About Entrepreneur Of The Year

Founded in 1986, Entrepreneur Of The Year has celebrated more than 11,000 ambitious visionaries who are leading successful, dynamic businesses in the US, and it has since expanded to nearly 60 countries globally. The US program consists of 17 regional programs whose panels of independent judges select the regional award winners every June. Those winners compete for national recognition at the Strategic Growth Forum® in November where National finalists and award winners are announced. The overall National winner represents the US at the EY World Entrepreneur Of The Year™ competition. Visit ey.com/us/eoy.

About Progress Software

Progress Software (Nasdaq: PRGS) empowers organizations to achieve transformational success in the face of disruptive change. Our software enables our customers to develop, deploy and manage responsible AI-powered applications and digital experiences with agility and ease. Customers get a trusted provider in Progress, with the products, expertise and vision they need to succeed. Over 4 million developers and technologists at hundreds of thousands of enterprises depend on Progress. Learn more at www.progress.com.

Progress is a trademark or registered trademark of Progress Software Corporation and/or its subsidiaries or affiliates in the U.S. and other countries. Any other names contained herein may be trademarks of their respective owners.

Press Contacts:

Kim Baker
Progress Software
+1-800-477-6473
[email protected]

A video accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/7fd7178e-98af-40f6-8027-c19233524eee



Posted on

Empower and Marvell Announce Collaboration on Next-Generation Integrated Power Delivery Solution for AI and Cloud Platforms

Initiative aims to develop high-performance optimized chip-level power delivery for 4+ kilowatt processors

SAN JOSE, Calif., June 18, 2025 (GLOBE NEWSWIRE) — Empower Semiconductor, the world leader in integrated voltage regulators (IVRs), announced today a collaboration with Marvell Technology, Inc. (NASDAQ: MRVL) to develop optimized integrated power solutions for Marvell® custom silicon platforms. These advanced solutions are designed to accelerate the transformation of power delivery systems to smaller, faster, integrated power silicon chips tightly coupled with the processor.

The joint solutions are part of Empower’s broader mission to address the power delivery challenges of the kilowatt-chip era. By integrating power delivery with advanced processors, Empower and Marvell enable hyperscalers and infrastructure providers to maximize their performance, efficiency, and return on investment (ROI) of artificial intelligence (AI) and cloud data centers.

“The collaboration with Marvell validates Empower’s technology as a foundational enabler of next-generation AI and cloud infrastructure,” commented Tim Phillips, CEO of Empower Semiconductor. “With integrated voltage regulation, we’re delivering power where it’s needed—right at the point of load—with exceptional density, precision and efficiency.”

“Placing integrated voltage regulators (IVR) under, near, or inside the package delivers greater performance and greater efficiency,” said Will Chu, senior vice president and general manager of Custom Cloud Solutions at Marvell. “We look forward to working with Empower to bring pre-validated packaged IVR power solutions to our custom XPU customers.”

The collaboration leverages Empower’s FinFast™ technology and vertical power delivery architecture to provide system designers with pre-validated, high-density power solutions that move voltage regulation from traditional board-level designs to silicon-integrated or near-chip solutions. By bringing power delivery closer to the processor, these solutions significantly reduce power transmission losses, improve efficiency, and support the increasing current demands of next-generation XPUs.

About Empower Semiconductor

Empower Semiconductor, based in Silicon Valley, powers the AI revolution with its FinFast™ technology by reducing the energy footprint and total cost of ownership of data centers. Its transformational integrated voltage regulators deliver on-demand scalable power with the speed, precision and signal integrity required by AI processors. Empower’s power-management architecture shrinks solution footprint, height and component count, achieving vertical power delivery with unprecedented power density and efficiency. Learn more at www.empowersemi.com and follow us on LinkedIn.

All trademarks and registered trademarks are the property of their respective owners.

Marvell and the M logo are trademarks of Marvell or its affiliates. Please visit www.marvell.com for a complete list of Marvell trademarks. Other names and brands may be claimed as the property of others.

This press release contains forward-looking statements within the meaning of the federal securities laws that involve risks and uncertainties. Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate or imply future events, results or achievements. Actual events, results or achievements may differ materially from those contemplated in this press release. Forward-looking statements are only predictions and are subject to risks, uncertainties and assumptions that are difficult to predict, Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and no person assumes any obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.

Media Contact for Empower Semiconductor:

Sandy Fewkes
Senior Public Relations Manager
Kiterocket
+1-408-529-9685
[email protected]



Posted on

Texas Instruments plans to invest more than $60 billion to manufacture billions of foundational semiconductors in the U.S.

PR Newswire

Leading U.S. companies Apple, Ford, Medtronic, NVIDIA and SpaceX strengthen partnerships with TI to unleash the next era of American innovation

NEWS HIGHLIGHTS:

  • More than $60 billion investment includes seven U.S. semiconductor fabs across three manufacturing mega-sites in Texas and Utah supporting more than 60,000 new U.S. jobs
  • Largest investment in foundational semiconductor manufacturing in U.S. history, building on TI’s almost-100-year legacy
  • TI’s largest mega-site in Sherman, Texas includes investment of up to $40 billion dollars for four fabs: SM1 and SM2 – already underway – and two additional fabs, SM3 and SM4
  • Leverages TI’s strengths as a global technology and manufacturing leader to advance critical innovations from vehicles to smartphones to data centers


DALLAS
, June 18, 2025 /PRNewswire/ — Texas Instruments (TI) (Nasdaq: TXN) today announced its plans to invest more than $60 billion across seven U.S. semiconductor fabs, making this the largest investment in foundational semiconductor manufacturing in U.S. history. Working with the Trump administration and building on the company’s nearly 100-year legacy, TI is expanding its U.S. manufacturing capacity to supply the growing need for semiconductors that will advance critical innovations from vehicles to smartphones to data centers. Combined, TI’s new manufacturing mega-sites in Texas and Utah will support more than 60,000 U.S. jobs.

“TI is building dependable, low-cost 300mm capacity at scale to deliver the analog and embedded processing chips that are vital for nearly every type of electronic system,” said Haviv Ilan, president and CEO of Texas Instruments. “Leading U.S. companies such as Apple, Ford, Medtronic, NVIDIA and SpaceX rely on TI’s world-class technology and manufacturing expertise, and we are honored to work alongside them and the U.S. government to unleash what’s next in American innovation.”

“For nearly a century, Texas Instruments has been a bedrock American company driving innovation in technology and manufacturing,” said U.S. Secretary of Commerce, Howard Lutnick. “President Trump has made it a priority to increase semiconductor manufacturing in America – including these foundational semiconductors that go into the electronics that people use every day. Our partnership with TI will support U.S. chip manufacturing for decades to come.”

Unleashing what’s next in American innovation

Today, TI is the largest foundational semiconductor manufacturer in the U.S., producing analog and embedded processing chips that are critical for smartphones, vehicles, data centers, satellites and nearly every other electronic device. In order to meet the steadily growing demand for these essential chips, TI is building on its legacy of technology leadership and expanding its U.S. manufacturing presence to help its customers pioneer the next wave of technological breakthroughs.

Igniting intelligence with Apple

“Texas Instruments’ American-made chips help bring Apple products to life, and together, we’ll continue to create opportunity, drive innovation, and invest in the future of advanced manufacturing across the U.S.,” said Apple’s CEO Tim Cook.

Fueling the future with Ford

Ford and TI are working to strengthen American manufacturing, combining Ford’s automotive expertise with TI’s semiconductor technology to help drive innovation and secure a robust, domestic supply chain for the future of mobility. “At Ford, 80% of the vehicles we sell in the U.S. are assembled in the U.S., and we are proud to stand with technology leaders like TI that continue to invest in manufacturing in the U.S.,” said Jim Farley, President and CEO of Ford Motor Company.

Connecting patient care with Medtronic

Medtronic and TI are partnering to improve lives when it matters most. “At Medtronic, our life-saving medical technologies rely on semiconductors to deliver precision, performance, and innovation at scale,” said Geoff Martha, Medtronic chairman and CEO. “Texas Instruments has been a vital partner – especially during the global chip shortages – helping us maintain supply continuity and accelerate the development of breakthrough therapies. We’re proud to leverage TI’s U.S.-manufactured semiconductors as we work to transform healthcare and improve outcomes for patients around the world.”

Advancing AI with NVIDIA

NVIDIA is partnering with TI to unleash the next generation of artificial intelligence architectures. “NVIDIA and TI share the goal to revitalize U.S. manufacturing by building more of the infrastructure for AI factories here in the U.S.,” said Jensen Huang, founder and CEO of NVIDIA. “We look forward to continuing our collaboration with TI by developing products for advanced AI infrastructure.”

Securing high-speed satellite internet with SpaceX

SpaceX is increasingly leveraging TI’s high-speed process technology to connect its Starlink satellite internet service with TI’s latest 300mm SiGe technology manufactured in Sherman, Texas. “Our fundamental mission is to revolutionize global connectivity and eliminate the digital divide. Core to this mission is constantly pushing the boundaries of what is possible,” said Gwynne Shotwell, president and COO of SpaceX. “SpaceX is manufacturing tens of thousands of Starlink kits a day – all right here in the U.S. – and we are making huge investments in PCB manufacturing and silicon packaging to expand even further. TI’s U.S.-made semiconductors are crucial for securing a U.S. supply chain for our products, and their advanced silicon manufacturing capabilities provide the performance and reliability needed to help us meet the growing demand for high-speed internet all around the world.”

Backed by
the strength of TI’s U.S. manufacturing presence

TI is a driving force behind the return and expansion of semiconductor manufacturing in the U.S. The company’s more than $60 billion investment in U.S. manufacturing includes building and ramping seven, large-scale, connected fabs. Combined, these fabs across three manufacturing mega-sites in Texas and Utah will manufacture hundreds of millions of U.S.-made chips daily that will ignite a bold new chapter in American innovation.


  • Sherman, Texas:     SM1, TI’s first new fab in Sherman will begin initial production this year, just three years after breaking ground. Construction is also complete on the exterior shell of SM2, TI’s second new fab in Sherman. Incremental investment plans include two additional fabs, SM3 and SM4, to support future demand.

  • Richardson, Texas:     TI’s second fab in Richardson, RFAB2, continues to ramp to full production and builds on the company’s legacy of introducing the world’s first 300mm analog fab, RFAB1, in 2011.

  • Lehi, Utah:     TI is ramping LFAB1, the company’s first 300mm wafer fab in Lehi. Construction is also well underway on LFAB2, TI’s second Lehi fab that will connect to LFAB1.

Learn more

About Texas Instruments

Texas Instruments Incorporated (Nasdaq: TXN) is a global semiconductor company that designs, manufactures, and sells analog and embedded processing chips for markets such as industrial, automotive, personal electronics, communications equipment and enterprise systems. At our core, we have a passion to create a better world by making electronics more affordable through semiconductors. This passion is alive today as each generation of innovation builds upon the last to make our technology more reliable, more affordable and lower power, making it possible for semiconductors to go into electronics everywhere. Learn more at TI.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/texas-instruments-plans-to-invest-more-than-60-billion-to-manufacture-billions-of-foundational-semiconductors-in-the-us-302485156.html

SOURCE Texas Instruments

Posted on

NYSE Content Advisory: Pre-Market update + Fed Decision on deck

PR Newswire


NEW YORK
, June 18, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 


Kristen Scholer delivers the pre-market update on June 18th

  • Stocks are fractionally higher Wednesday morning as traders continue to monitor conflict in the Middle East. Major averages ended Tuesday’s session lower while the price of crude oil rose by 4%
  • According to NBC News, President Trump is weighing options on Iran, including whether to launch a military strike. The President weighed in on Truth Social demanding “unconditional surrender.”
  • Traders are paying close attention to this afternoon’s Fed Decision, due at 2 PM ET. Economists believe it is a near-certainty that rates remain unchanged. What’s uncertain is the guidance Chair Powell will provide in his subsequent remarks.


Opening Bell

Allied Gold (NYSE: AAUC) celebrates their recent listing on the New York Stock Exchange


Closing Bell

NCPERS celebrates the close of Chief Officers Summit 25


Click here to download the NYSE TV App

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/nyse-content-advisory-pre-market-update–fed-decision-on-deck-302485186.html

SOURCE New York Stock Exchange

Posted on

Akari Therapeutics Bolsters Global IP Estate for its Novel Antibody Drug Conjugate (ADC) Immuno-Oncology Payload, PH1, with Recent Granting of Patent Protection Across India

Differentiated PH1 payload is a spliceosome inhibitor designed to inhibit RNA splicing, leading to cancer cell death and activation of immune system through multiple mechanisms

India represents a key territory with a rapidly growing incidence rate of cancer cases, projected to increase to 2.08 million by 2040

1

BOSTON and LONDON, June 18, 2025 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel immuno-oncology payload antibody drug conjugates (ADCs) for the treatment of cancer, today announced the Intellectual Property India (IPI) has issued Patent No. 562,919 titled, “Thailanstatin Analogs”.

The issued patent covers claims for the Company’s potent immuno-oncology PH1 payload, proprietary non-cleavable and cleavable linkers and ADC technology which has applications across various cancer targets.

“We believe our innovative ADC payload PH1 has the potential to provide therapies that disrupt cellular function, trigger cancer cell death and most importantly, enhance the immune system to fight cancer beyond the cells targeted by the ADC molecule. The issuance of this patent further strengthens our global intellectual property estate and importantly, provides additional patent protection around our CMC manufacturing activities for this PH1 payload and related analogs. Importantly, as cancer rates and diagnosis continue to rise significantly in India, we believe the need for innovative cancer therapies continue to increase. We are pleased to bolster our intellectual property portfolio to include this key market for future opportunities to potentially help cancer patients with our immuno-oncology ADCs,” commented Abizer Gaslightwala, President and CEO of Akari Therapeutics.

The issued India patent is a divisional patent of the Company’s R&D toxin portfolio on PH1 and builds on the portfolio of previously issued patents (Patent No. US 10,815,246 B2, Patent No. US 10,301,319 B2 and Patent No. US 11,691,982 B2). Grant Patent right for PCT/US2018/051721 family was issued by China National Intellectual Property Administration in August 2023, and in Israel in September 2023. Corresponding foreign patent applications are pending and currently undergoing examination in Patent Cooperation Treaty (“PCT”) countries – Brazil, Canada, member states of the European Patent Organisation (“EPO”), Hong Kong, Japan, New Zealand, Singapore, & South Africa.

Leveraging its innovative payload platform, the Company is advancing a pipeline of potentially first-in-class, best-in-class ADC candidates across a wide range of cancer tumor targets. These initial candidates have shown significant tumor-killing activity in preclinical models with the ability to robustly activate the immune system to drive durable, and sustained outcomes.

About Akari Therapeutics

Akari Therapeutics is an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs). The Company has developed its first novel payload, PH1, a spliceosome inhibitor designed to disrupt RNA splicing within cells. PH1 is highly differentiated in its mechanism of action against cancer cells from current ADC payloads that use Topoisomerase1 inhibitors or tubulin inhibitors. This splicing inhibition has been shown in preclinical animal models to induce cancer cell death while activating immune cells to drive robust and durable activity. Using this novel payload, Akari has the ability to generate multiple ADC molecules based on the desired application to a range of cancer targets of interest. Akari’s lead candidate, AKTX-101, targets the Trop2 receptor on cancer cells and with a proprietary linker, delivers its novel PH1 payload directly into the tumor. In preclinical studies, AKTX-101 has shown to have significant activity and prolonged survival, relative to ADCs with traditional payloads. Additionally, AKTX-101 has the potential to be synergistic with checkpoint inhibitors and has demonstrated prolonged survival as both a single agent and in combination with checkpoint inhibitors, as compared to appropriate controls. The Company is generating validating data on its novel payload PH1 to continue advancing its lead asset, as well as other undisclosed targets with this novel payload.

For more information about the Company, please visit www.akaritx.com and connect on X and LinkedIn.

Cautionary Note Regarding Forward-Looking Statements 

This press release includes express or implied forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, about the Company that involve risks and uncertainties relating to future events and the future performance of the Company. Actual events or results may differ materially from these forward-looking statements. Words such as “will,” “could,” “would,” “should,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “future,” “opportunity” “will likely result,” “target,” variations of such words, and similar expressions or negatives of these words are intended to identify such forward-looking statements, although not all forward-looking statements contain these identifying words. Examples of such forward-looking statements include, but are not limited to, express or implied statements regarding the ability of the Company to advance its product candidates for the treatment of cancer and any other diseases, and ultimately bring therapies to patients; the Company’s targets, plans, objectives or goals for future operations, including those related to its product candidates. These statements are based on the Company’s current plans, estimates and projections. By their very nature, forward-looking statements involve inherent risks and uncertainties, both general and specific. A number of important factors, including those described in this communication, could cause actual results to differ materially from those contemplated in any forward-looking statements. Factors that may affect future results and may cause these forward-looking statements to be inaccurate include, without limitation: the potential impact of unforeseen liabilities, future capital expenditures, revenues, costs, expenses, earnings, synergies, economic performance, indebtedness, financial condition and losses on the future prospects, business and management strategies for the management, expansion and growth of the business; risks related to global as well as local political and economic conditions, including interest rate and currency exchange rate fluctuations; potential delays or failures related to research and/or development of the Company’s programs or product candidates; risks related to any loss of the Company’s patents or other intellectual property rights; any interruptions of the supply chain for raw materials or manufacturing for the Company’s product candidates, including as a result of potential tariffs; the nature, timing, cost and possible success and therapeutic applications of product candidates being developed by the Company and/or its collaborators or licensees; the extent to which the results from the research and development programs conducted by the Company, and/or its collaborators or licensees may be replicated in other studies and/or lead to advancement of product candidates to clinical trials, therapeutic applications, or regulatory approval; uncertainty of the utilization, market acceptance, and commercial success of the Company’s product candidates; risks related to competition for the Company’s product candidates; and the Company’s ability to successfully develop or commercialize its product candidates. While the foregoing list of factors presented here is considered representative, no list should be considered to be a complete statement of all potential risks and uncertainties. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the SEC, copies of which may be obtained from the SEC’s website at www.sec.gov. The Company assumes no, and hereby disclaims any, obligation to update the forward-looking statements contained in this press release except as required by law.

Investor Relations Contact

JTC Team, LLC
Jenene Thomas
908-824-0775
[email protected] 

1
https://pmc.ncbi.nlm.nih.gov/articles/PMC10231735/#R2



Posted on

LGHL Secures $600 Million Facility to Launch Hyperliquid (HYPE) Treasury

PR Newswire

-Vision to Build the Largest HYPE Treasury Globally-

– Marks the Relaunch of LGHL’s Crypto Operations and Shift Toward On-Chain Finance-


SINGAPORE
, June 18, 2025 /PRNewswire/ — Lion Group Holding Ltd. (Nasdaq: LGHL) (“LGHL” or the “Company”) today announced it has secured a $600 million facility from ATW Partners to support the launch of its HYPE Treasury and on-chain initiative.

  • Strategic accumulation of HYPE to serve as the Company’s primary reserve asset
  • Launch of next-generation layer-1s treasury reserve, anchored by Hyperliquid (HYPE), Solana (SOL) and Sui (SUI)
  • SOL and SUI assets will be custodied and staked with validators managed by BitGo Trust Company, Inc. (“BitGo”)
  • Evaluate secondary listings on the Tokyo Stock Exchange (TSE) and Singapore Exchange (SGX) to broaden global reach and create the first HYPE treasury listed in Asia

“Hyperliquid represents a natural extension of LGHL’s existing derivatives business into decentralized markets, and reflects our conviction that decentralized on-chain execution is the future of trading,” said Mr. Wilson Wang, CEO of LGHL. “We view protocols like HYPE, with decentralized sequencing, as foundational to building scalable DeFi systems. We may also allocate to Solana (SOL), a leader in consumer-facing applications, and Sui (SUI), a performant, composable layer-1 with recent backing from Eric Trump’s World Liberty Financial – both forming key pillars to our treasury strategy focused on execution-first protocols.”

As adoption of on-chain applications accelerates, LGHL believes combining public market access with a next-generation layer-1s treasury will resonate with global investors and drive long-term shareholder value. This initiative marks the Company’s relaunch of crypto operations and advances its strategic shift toward digital assets.

“We are proud to support LGHL’s strategic expansion into Solana and Sui with our institutional-grade custody and trading solutions,” said Mike Belshe, CEO of BitGo. “This $600 million facility reflects a clear signal that institutional investors are accelerating their diversification into next-generation blockchain ecosystems. BitGo is positioned to power this next wave of institutional adoption, and we’re excited to serve as LGHL’s trusted partner at the forefront of this new phase in digital asset treasury management.”

To safeguard and maximize the potential of their digital asset holdings, LGHL has partnered with BitGo, the leading infrastructure provider of digital asset solutions. BitGo is the largest custodian of Solana and the leading staking provider across all digital assets, providing unparalleled expertise and access to increased rewards through its full-service platform. BitGo will safeguard the Company’s assets, leveraging its industry-leading technology, operational controls, and regulatory compliance.

The first closing of $10.6 million in subscription amount is expected to occur in the next 48 hours.

Chardan acted as the sole placement agent in connection with the facility.

The foregoing description does not purport to be complete and is qualified in its entirety by reference to the full text of the Company’s current report on Form 6-K dated June 18, 2025.

About Lion Group Holding Ltd.

Lion Group Holding Ltd. (Nasdaq: LGHL) operates an all-in-one, state-of-the-art trading platform that offers a wide spectrum of products and services, including (i) total return swap (TRS) trading, (ii) contract-for-difference (CFD) trading, (iii) Over-the-counter (OTC) stock options trading, and (iv) futures and securities brokerage. Additional information may be found at http://ir.liongrouphl.com.

Forward-Looking Statements

This press release contains, “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Lion’s actual results may differ from their expectations, estimates and projections and consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “might” and “continues,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include, but are not limited to, statements about: Lion’s goals and strategies; our ability to retain and increase the number of users, members and advertising customers, and expand its service offerings; Lion’s future business development, financial condition and results of operations; expected changes in Lion’s revenues, costs or expenditures; competition in the industry; relevant government policies and regulations relating to our industry; general economic and business conditions globally; proposed crypto asset management operations; and assumptions underlying or related to any of the foregoing. Lion cautions that the foregoing list of factors is not exclusive. Lion cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Lion does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based, subject to applicable law. Additional information concerning these and other factors that may impact our expectations and projections can be found in Lion’s periodic filings with the SEC, including Lion’s Annual Report on Form 20-F for the fiscal year ended December 31, 2024. Lion’s SEC filings are available publicly on the SEC’s website at www.sec.gov.

Contacts
Lion Group Holding Ltd.
Tel: +65 8877 3871
Email: [email protected]

 

Cision View original content:https://www.prnewswire.com/news-releases/lghl-secures-600-million-facility-to-launch-hyperliquid-hype-treasury-302485190.html

SOURCE Lion Group Holding Ltd.